Biodefense Summit: Implementing the National Biodefense Strategy: Notification of Public Meeting and Solicitation of Advice, 12628 [2019-06330]
Download as PDF
12628
Federal Register / Vol. 84, No. 63 / Tuesday, April 2, 2019 / Notices
one of whom is a state, tribal, territorial,
or local public health official. The
Secretary appoints members who are
not full-time or permanent part-time
federal employees as non-pay special
government employees.
Dated: March 27, 2019.
Robert P. Kadlec,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2019–06329 Filed 4–1–19; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Biodefense Summit: Implementing the
National Biodefense Strategy:
Notification of Public Meeting and
Solicitation of Advice
Office of the Assistant
Secretary for Preparedness and
Response (ASPR), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The HHS Assistant Secretary
for Preparedness and Response (ASPR)
in the Department of Health and Human
Services (HHS) is announcing a public
meeting, Biodefense Summit:
Implementing the National Biodefense
Strategy (Strategy). Implementing the
Strategy involves partners among
multiple sectors, including medical;
public, animal, and plant health;
emergency response; scientific and
technical; law enforcement; industrial;
academic; diplomatic; defense and
security; intelligence; and
nonproliferation and
counterproliferation stakeholders. This
meeting is being held to introduce the
Strategy to these groups and to solicit
feedback from them. The meeting will
be open to representatives from invited
organizations and the public.
DATES: The meeting will be held on
April 17, 2019, from 8:45 a.m. to 5:00
p.m.
ADDRESSES: National Academies of
Sciences Building, 2101 Constitution
Ave. NW, Washington, DC 20418.
FOR FURTHER INFORMATION CONTACT:
CAPT Theresa Lawrence, Ph.D.;
Director, Division of Policy, Office of
Strategy, Policy, Planning, and
Requirements, Office of the Assistant
Secretary for Preparedness and
Response, Office of the Secretary of the
Department of Health and Human
Services; Thomas P. O’Neill Jr. Federal
Building; 200 C St SW, Washington, DC
20515; Theresa.Lawrence@HHS.GOV;
202–401–5879
SUPPLEMENTARY INFORMATION:
amozie on DSK9F9SC42PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:45 Apr 01, 2019
Jkt 247001
Agenda: On April 17, 2019, ASPR
will convene a meeting at the National
Academies of Sciences Building, 2101
Constitution Ave. NW, Washington, DC
20418 from 8:45 a.m.–5:00 p.m. with
non-federal stakeholders to discuss and
solicit input on implementing the
National Biodefense Strategy, pursuant
to National Security Presidential
Memorandum 14, signed September 18,
2018.
The meeting will focus on a set of
questions on the meeting agenda, posted
at https://www.phe.gov/biodefense, on
which the U.S. Government would
specifically like to solicit comment.
These questions concern matters such as
the identification of gaps and
opportunities for improvement in
biodefense.
The meeting will be conducted as a
series of panels where participants will
be asked to discuss particular topics of
interest to the Government. Each panel
will include ample time for in-depth
discussion of the issues surrounding
each topic.
The meeting is open to the public and
free of charge. Pre-registration is
encouraged, however, registration will
be restricted due to limited space.
Information about registering for the
meeting is available at https://
www.phe.gov/biodefense. Any groups or
individuals who cannot attend the
meeting are encouraged to submit
written comments.
Background: Biological threats are
among the most serious threats facing
the United States. In today’s
interconnected world, biological
incidents have the potential to cost
thousands of American lives, cause
significant anxiety, and disrupt travel
and trade. The Strategy sets the course
for the United States to combat the
serious biothreats our country faces,
whether they arise from natural
outbreaks of disease, accidents
involving high consequence pathogens,
or the actions of terrorists or state actors.
Preparing for biothreats is a critical
aspect of our national security, and the
Strategy encompasses five goals for
strengthening the biodefense enterprise
including:
1. Enabling risk awareness to inform
decision-making across the biodefense
enterprise;
2. Ensuring biodefense enterprise
capabilities to prevent bioincidents;
3. Ensuring biodefense enterprise
preparedness to reduce the impacts of
bioincidents;
4. Rapidly responding to limit the
impacts of bioincidents; and
5. Facilitating recovery to restore the
community, the economy, and the
environment after a bioincident.
PO 00000
Frm 00054
Fmt 4703
Sfmt 9990
The National Biodefense Strategy
calls for engagement and cooperation
across all levels of government, to
include state, local, tribal, and territorial
governments, as well as internationally.
It involves partnership with multiple
sectors, including the medical; public,
animal, and plant health; emergency
response; scientific and technical; law
enforcement; industrial; academic;
diplomatic; defense and security;
intelligence; and nonproliferation and
counterproliferation sectors, among
others. Engagement with nongovernmental organizations and the
private sector is critical to prevent the
spread of disease and respond to the
next outbreak before it becomes an
epidemic.
Streaming Webcast of the Public
Meeting: This public meeting will also
be webcast. Information about
registering for the webcast will be
available at https://www.phe.gov/
biodefense.
Meeting Summary: Please be advised
that a summary of the meeting will be
accessible at https://www.phe.gov/
biodefense as soon as it is available.
Written Public Input is Encouraged:
Even though space or time constraints
may preclude some interested members
of the public from attending, we
understand that these issues are broadly
of interest to the American people.
Given the importance of the Nation’s
biodefense to every American, the
public is encouraged to submit written
comments on a set of questions on the
meeting agenda posted at www.phe.gov/
biodefense, on which the U.S.
Government would specifically like to
solicit comment. These questions
concern such matters as the
identification of gaps and opportunities
for improvement in biodefense.
Comments should be submitted to
ASPRBIO@hhs.gov or the address above
by May 1, 2019.
Dated: March 27, 2019.
Robert P. Kadlec,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2019–06330 Filed 4–1–19; 8:45 am]
BILLING CODE 4150–37–P
E:\FR\FM\02APN1.SGM
02APN1
Agencies
[Federal Register Volume 84, Number 63 (Tuesday, April 2, 2019)]
[Notices]
[Page 12628]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Biodefense Summit: Implementing the National Biodefense Strategy:
Notification of Public Meeting and Solicitation of Advice
AGENCY: Office of the Assistant Secretary for Preparedness and Response
(ASPR), Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The HHS Assistant Secretary for Preparedness and Response
(ASPR) in the Department of Health and Human Services (HHS) is
announcing a public meeting, Biodefense Summit: Implementing the
National Biodefense Strategy (Strategy). Implementing the Strategy
involves partners among multiple sectors, including medical; public,
animal, and plant health; emergency response; scientific and technical;
law enforcement; industrial; academic; diplomatic; defense and
security; intelligence; and nonproliferation and counterproliferation
stakeholders. This meeting is being held to introduce the Strategy to
these groups and to solicit feedback from them. The meeting will be
open to representatives from invited organizations and the public.
DATES: The meeting will be held on April 17, 2019, from 8:45 a.m. to
5:00 p.m.
ADDRESSES: National Academies of Sciences Building, 2101 Constitution
Ave. NW, Washington, DC 20418.
FOR FURTHER INFORMATION CONTACT: CAPT Theresa Lawrence, Ph.D.;
Director, Division of Policy, Office of Strategy, Policy, Planning, and
Requirements, Office of the Assistant Secretary for Preparedness and
Response, Office of the Secretary of the Department of Health and Human
Services; Thomas P. O'Neill Jr. Federal Building; 200 C St SW,
Washington, DC 20515; [email protected]; 202-401-5879
SUPPLEMENTARY INFORMATION:
Agenda: On April 17, 2019, ASPR will convene a meeting at the
National Academies of Sciences Building, 2101 Constitution Ave. NW,
Washington, DC 20418 from 8:45 a.m.-5:00 p.m. with non-federal
stakeholders to discuss and solicit input on implementing the National
Biodefense Strategy, pursuant to National Security Presidential
Memorandum 14, signed September 18, 2018.
The meeting will focus on a set of questions on the meeting agenda,
posted at https://www.phe.gov/biodefense, on which the U.S. Government
would specifically like to solicit comment. These questions concern
matters such as the identification of gaps and opportunities for
improvement in biodefense.
The meeting will be conducted as a series of panels where
participants will be asked to discuss particular topics of interest to
the Government. Each panel will include ample time for in-depth
discussion of the issues surrounding each topic.
The meeting is open to the public and free of charge. Pre-
registration is encouraged, however, registration will be restricted
due to limited space. Information about registering for the meeting is
available at https://www.phe.gov/biodefense. Any groups or individuals
who cannot attend the meeting are encouraged to submit written
comments.
Background: Biological threats are among the most serious threats
facing the United States. In today's interconnected world, biological
incidents have the potential to cost thousands of American lives, cause
significant anxiety, and disrupt travel and trade. The Strategy sets
the course for the United States to combat the serious biothreats our
country faces, whether they arise from natural outbreaks of disease,
accidents involving high consequence pathogens, or the actions of
terrorists or state actors. Preparing for biothreats is a critical
aspect of our national security, and the Strategy encompasses five
goals for strengthening the biodefense enterprise including:
1. Enabling risk awareness to inform decision-making across the
biodefense enterprise;
2. Ensuring biodefense enterprise capabilities to prevent
bioincidents;
3. Ensuring biodefense enterprise preparedness to reduce the
impacts of bioincidents;
4. Rapidly responding to limit the impacts of bioincidents; and
5. Facilitating recovery to restore the community, the economy, and
the environment after a bioincident.
The National Biodefense Strategy calls for engagement and
cooperation across all levels of government, to include state, local,
tribal, and territorial governments, as well as internationally. It
involves partnership with multiple sectors, including the medical;
public, animal, and plant health; emergency response; scientific and
technical; law enforcement; industrial; academic; diplomatic; defense
and security; intelligence; and nonproliferation and
counterproliferation sectors, among others. Engagement with non-
governmental organizations and the private sector is critical to
prevent the spread of disease and respond to the next outbreak before
it becomes an epidemic.
Streaming Webcast of the Public Meeting: This public meeting will
also be webcast. Information about registering for the webcast will be
available at https://www.phe.gov/biodefense.
Meeting Summary: Please be advised that a summary of the meeting
will be accessible at https://www.phe.gov/biodefense as soon as it is
available.
Written Public Input is Encouraged: Even though space or time
constraints may preclude some interested members of the public from
attending, we understand that these issues are broadly of interest to
the American people. Given the importance of the Nation's biodefense to
every American, the public is encouraged to submit written comments on
a set of questions on the meeting agenda posted at www.phe.gov/biodefense, on which the U.S. Government would specifically like to
solicit comment. These questions concern such matters as the
identification of gaps and opportunities for improvement in biodefense.
Comments should be submitted to [email protected] or the address above by
May 1, 2019.
Dated: March 27, 2019.
Robert P. Kadlec,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2019-06330 Filed 4-1-19; 8:45 am]
BILLING CODE 4150-37-P